Current management of iron deficiency anemia in inflammatory bowel diseases: a practical guide (Q38151564)

29 August 2017

Current management of iron deficiency anemia in inflammatory bowel diseases: a practical guide (English)

1 reference

inflammatory bowel diseases

29 August 2017

0 references

deficiency anemia

1 reference

inferred from title

iron deficiency anemia

1 reference

2

1 reference

29 August 2017

Fernando Gomollón

1

1 reference

29 August 2017

1 November 2013

1 reference

29 August 2017

1 reference

29 August 2017

73

1 reference

29 August 2017

1761-1770

1 reference

29 August 2017

16

1 reference

https://scigraph.springernature.com/pub.10.1007/s40265-013-0131-2

29 August 2017

0 references

cites work

Anemia in IBD: the overlooked villain

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Pathogenesis and treatment of anemia in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Iron deficiency anemia in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Effects of changes in hemoglobin level on quality of life and cognitive function in inflammatory bowel disease patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Risk factors for mortality in major digestive surgery in the elderly: a multicenter prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Risk factors for complications after bowel surgery in Korean patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Economic burden of patients with anemia in selected diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Systematic review: managing anaemia in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Iron and inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Prevalence and pathogenesis of anemia in inflammatory bowel disease. Influence of anti-tumor necrosis factor-alpha treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Disorders of iron metabolism. Part II: iron deficiency and iron overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Anaemia in inflammatory rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Prevalence of anaemia in inflammatory bowel disease in Switzerland: a cross-sectional study in patients from private practices and university hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Impaired intestinal iron absorption in Crohn's disease correlates with disease activity and markers of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Anemia of chronic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Diagnosis and management of anaemia of chronic disease: current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Iron regulation by hepcidin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Hepcidin and iron homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Iron sensing and signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Hepcidin is a key mediator of anemia of inflammation in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Structural basis for iron piracy by pathogenic Neisseria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Hepcidin and the iron-infection axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

GERD: GERD and insomnia-first degree relatives or distant cousins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

State of the iron: how to diagnose and efficiently treat iron deficiency anemia in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Assessing iron status: beyond serum ferritin and transferrin saturation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Diagnosing anemia in inflammatory bowel disease: beyond the established markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Measurement of reticulocyte and red blood cell indices in the evaluation of anemia in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Guidelines on the diagnosis and management of iron deficiency and anemia in inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Effect of adalimumab on clinical laboratory parameters in patients with Crohn's disease: results from the CHARM trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Common misconceptions in the diagnosis and management of anemia in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Iron supplementation for unexplained fatigue in non-anaemic women: double blind randomised placebo controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Intravenous iron for the treatment of fatigue in nonanemic, premenopausal women with low serum ferritin concentration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Effect of iron supplementation on fatigue in nonanemic menstruating women with low ferritin: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Effect of iron therapy on platelet counts in patients with inflammatory bowel disease-associated anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Thrombocytosis and venous thromboembolism in cancer patients with chemotherapy induced anemia may be related to ESA induced iron restricted erythropoiesis and reversed by administration of IV iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Detection, evaluation, and management of iron-restricted erythropoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Iron deficiency syndromes and iron-restricted erythropoiesis (CME).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Iron: the new advances in therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Diagnosis and management of iron deficiency anemia in the 21st century

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Oral and intravenous iron treatment in inflammatory bowel disease: hematological response and quality of life improvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Iron replacement therapy in inflammatory bowel disease patients with iron deficiency anemia: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Effect of iron supplementation on oxidative stress and intestinal inflammation in rats with acute colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Ferrous fumarate deteriorated plasma antioxidant status in patients with Crohn disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Effects of ferrous sulphate and non-ionic iron-polymaltose complex on markers of oxidative tissue damage in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Supplementation with oral vs. intravenous iron for anemia with IBD or gastrointestinal bleeding: is oral iron getting a bad rap?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Toxicity of iron and hydrogen peroxide: the Fenton reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Iron-induced mucosal pathology of the upper gastrointestinal tract: a common finding in patients on oral iron therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Depletion of luminal iron alters the gut microbiota and prevents Crohn's disease-like ileitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Nutrition & Metabolism: an impressive performance since inception

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

21 January 2018

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Oral and intravenous iron therapy in the anaemia of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Are we giving too much iron? Low-dose iron therapy is effective in octogenarians

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Toxic reactions after intravenous saccharated iron oxide in man; suggestions for improved preparations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

When is high-dose intravenous iron repletion needed? Assessing new treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Intravenous iron: from anathema to standard of care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Use of parenteral iron products and serious anaphylactic-type reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

A shift from oral to intravenous iron supplementation therapy is observed over time in a large swiss cohort of patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Oral ferrous fumarate or intravenous iron sucrose for patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Update on adverse drug events associated with parenteral iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Comparative study of gastrointestinal tract and liver toxicity of ferrous sulfate, iron amino chelate and iron polymaltose complex in normal rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Clinical use of intravenous iron: administration, efficacy, and safety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Safety and efficacy of total-dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Ferric carboxymaltose: a review of its use in iron-deficiency anaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Iron (III) isomaltoside 1000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Update of a comparative analysis of cost minimization following the introduction of newly available intravenous iron therapies in hospital practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Do two intravenous iron sucrose preparations have the same efficacy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Iron requirements based upon iron absorption tests are poorly predicted by haematological indices in patients with inactive inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Stimulating erythropoiesis in inflammatory bowel disease associated anemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Use of agents stimulating erythropoiesis in digestive diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Concepts of blood transfusion in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Blood transfusion for the treatment of acute anaemia in inflammatory bowel disease and other digestive diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Blood management: transfusion medicine comes of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Transfusion strategies for acute upper gastrointestinal bleeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Appropriateness of allogeneic red blood cell transfusion: the international consensus conference on transfusion outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Alternatives to blood transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Safety and efficacy of total dose infusion of 1,020 mg of ferumoxytol administered over 15 min.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40265-013-0131-2

Intravenous iron and erythropoietin for anemia associated with Crohn disease. A randomized, controlled trial

21 January 2018

1 reference

12 December 2020

Pharmacokinetics of iron isomaltoside 1000 in patients with inflammatory bowel disease

1 reference

12 December 2020

Extraintestinal manifestations and complications in IBD.

1 reference

12 December 2020

A comparative study of the physicochemical properties of iron isomaltoside 1000 (Monofer), a new intravenous iron preparation and its clinical implications

1 reference

12 December 2020

Iron deficiency generates secondary thrombocytosis and platelet activation in IBD: the randomized, controlled thromboVIT trial

1 reference

12 December 2020

Oral iron therapy in inflammatory bowel disease: usage, tolerance, and efficacy

1 reference

12 December 2020

Anemia ferropénica y uso de hierro endovenoso en patología digestiva

1 reference

12 December 2020

Diagnosis and management of iron deficiency anemia in patients with IBD.

1 reference

12 December 2020

Iron supplementation may aggravate inflammatory status of colitis in a rat model

1 reference

12 December 2020

Economic evaluation of intravenous iron treatments in the management of anemia patients in Greece

1 reference

12 December 2020

Patients enrolled in randomized controlled trials do not represent the inflammatory bowel disease patient population

1 reference

12 December 2020

Treatment of iron deficiency

1 reference

12 December 2020

Cause of death in patients with inflammatory bowel disease

1 reference

12 December 2020

Dietary fortificant iron intake is negatively associated with quality of life in patients with mildly active inflammatory bowel disease

1 reference

12 December 2020

High prevalence but insufficient treatment of iron-deficiency anemia in patients with inflammatory bowel disease: results of a population-based cohort

1 reference

12 December 2020

Prediction of response to iron sucrose in inflammatory bowel disease-associated anemia

1 reference

12 December 2020

Association between thrombocytosis and iron deficiency anemia in inflammatory bowel disease

1 reference

12 December 2020

Ferric Carboxymaltose Prevents Recurrence of Anemia in Patients With Inflammatory Bowel Disease

1 reference

12 December 2020

[Anemia and inflammatory bowel disease]

1 reference

12 December 2020

Iron supplementation increases disease activity and vitamin E ameliorates the effect in rats with dextran sulfate sodium-induced colitis

1 reference

12 December 2020

Structure, chemistry, and pharmacokinetics of intravenous iron agents

1 reference

12 December 2020

Observations on the effect of massive doses of iron given intravenously to patients with hypochromic anemia

1 reference

12 December 2020

Prevalence and management of anemia in children, adolescents, and adults with inflammatory bowel disease

1 reference

12 December 2020

Iron deficiency and reduced work capacity: a critical review of the research to determine a causal relationship

1 reference

12 December 2020

Oral or IV iron in inflammatory bowel disease

1 reference

12 December 2020

Revaluating serum ferritin as a marker of body iron stores in the traceability era.

1 reference

12 December 2020

Soluble transferrin receptor (sTfR) and sTfR/log ferritin index for the diagnosis of iron-deficiency anemia. A meta-analysis

1 reference

12 December 2020

Intravenous iron sucrose is superior to oral iron sulphate for correcting anaemia and restoring iron stores in IBD patients: A randomized, controlled, evaluator-blind, multicentre study

1 reference

12 December 2020

Refractory iron-deficiency anaemia treated with intravenous saccharated oxide of iron

1 reference

12 December 2020

10.1007/S40265-013-0131-2

Identifiers

DOI

1 reference

PubMed ID

24114623

Dimensions Publication ID

29 August 2017

0 references

1 reference

PubMed ID

24114623